![PDF) P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases PDF) P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases](https://i1.rgstatic.net/publication/330643099_P251_RAID_Dx_the_first_test_based_on_faecal_microbiota_to_differentiate_irritable_bowel_syndrome_from_inflammatory_bowel_diseases/links/5d2c7ecb92851cf44085591e/largepreview.png)
PDF) P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases
The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis
Rishi Fofaria on Twitter: "Follow-up study showed excellent outcomes for stratified tele-monitored patients as per IBD #ICHOM outcome measures (incl ⬇️healthcare utilisation and ⬇️steroid use) - https://t.co/skeMvCou6i @ICHOM_ORG @BritSocGastro ...
![PDF) P749 Epidemiological and clinical characterisation of inflammatory bowel disease (IBD) in Latin America and the Caribbean: The EPI-LATAM IBD study from the Pan American Crohn's colitis organisation PDF) P749 Epidemiological and clinical characterisation of inflammatory bowel disease (IBD) in Latin America and the Caribbean: The EPI-LATAM IBD study from the Pan American Crohn's colitis organisation](https://i1.rgstatic.net/publication/338647111_P749_Epidemiological_and_clinical_characterisation_of_inflammatory_bowel_disease_IBD_in_Latin_America_and_the_Caribbean_The_EPI-LATAM_IBD_study_from_the_Pan_American_Crohn's_colitis_organisation/links/5f1383a34585151299a6e205/largepreview.png)